Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Clinical Reviews in Allergy & Immunology
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2010

01.12.2010

Reproductive Immunology: Current Status and Future Directions (Part I)

verfasst von: Elena Peeva

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Extensive research work over the past couple of decades has indicated a series of intricate relations between immune and reproductive systems. A range of reproductive immunology topics including the roles of adoptive and innate immunity in infertility and pregnancy, the immune system’s role in induction of labor and preterm delivery, and immuno-modulatory effects of the female sex hormones will be discussed in this and the next issue of the Journal. The implications of this research on the development of novel therapeutic approaches are also addressed.
Literatur
1.
Cervera R, Balasch J (2008) Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 14:359–366CrossRefPubMed
2.
Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372CrossRefPubMed
3.
4.
Alonso N, Soldevila B, Sanmarti A, Pujol-Borrell R, Martinez-Caceres E (2009) Regulatory T cells in diabetes and gastritis. Autoimmun Rev 8:659–662CrossRefPubMed
5.
Bertsias G, Nakou M, Choulaki C et al (2009) Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum 60:207–218CrossRefPubMed
6.
Bianco N, Kim S, Ruffner M, Robbins P (2009) Therapeutic effect of exosomes from indoleamine 2, 3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60:380–389CrossRefPubMed
7.
Carissimi C, Fulci V, Macino G (2009) MicroRNAs: novel regulators of immunity. Autoimmun Rev 8:520–524CrossRefPubMed
8.
Davies A (2008) Immunological tolerance and the autoimmune response. Autoimmun Rev 7:538–543CrossRefPubMed
9.
Frazer I (2008) Autoimmunity and persistent viral infection: two sides of the same coin? J Autoimmun 3:216–218CrossRef
10.
Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8:384–387CrossRefPubMed
11.
Gomez-Martin D, Diaz-Zamudio M, Crispin J, Alcocer-Varela J (2009) Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun Rev 9:34–39CrossRefPubMed
12.
Gonzalez M, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006–1019CrossRefPubMed
13.
Harrison L, Honeyman M, Morahan G et al (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310CrossRefPubMed
14.
Hewagama A, Richardson B (2009) The genetics and epigenetics of autoimmune diseases. J Autoimmun 33:3–11CrossRefPubMed
15.
Hogan T, Ang D, Gleeson P, van Driel I (2008) Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis. J Autoimmun 31:268–273CrossRefPubMed
16.
Ikehara S (2008) A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J Autoimmun 30:108–115CrossRefPubMed
17.
Jamin C, Morva A, Lemoine S, Daridon C, de Mendoza A, Youinou P (2008) Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 58:1900–1906CrossRefPubMed
18.
19.
Kessel A, Bamberger E, Masalha M, Toubi E (2009) The role of T regulatory cells in human sepsis. J Autoimmun 32:211–215CrossRefPubMed
20.
Kristof K, Erdei A, Bajtay Z (2008) Set a thief to catch a thief: self-reactive innate lymphocytes and self tolerance. Autoimmun Rev 7:278–283CrossRefPubMed
21.
Kushida T, Ueda Y, Umeda M et al (2009) Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice. J Autoimmun 32:216–222CrossRefPubMed
22.
Morahan G, Peeva V, Mehta M, Williams R (2008) Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 31:233–236CrossRefPubMed
23.
Pai S, Thomas R (2008) Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity. J Autoimmun 31:245–251CrossRefPubMed
24.
Peron J, de Oliveira A, Rizzo L (2009) It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev 9:1–4CrossRefPubMed
25.
Satpute S, Rajaiah R, Polumuri S, Moudgil K (2009) Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses. Arthritis Rheum 60:103–113CrossRefPubMed
26.
Wermeling F, Karlsson M, McGaha T (2009) An anatomical view on macrophages in tolerance. Autoimmun Rev 9:49–52CrossRefPubMed
27.
Youinou P, Jamin C (2009) The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 32:206–210CrossRefPubMed
28.
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E (2009) Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 60:1743–1752CrossRefPubMed
29.
Abdulghani S, Caetano-Lopes J, Canhao H, Fonseca J (2009) Biomechanical effects of inflammatory diseases on bone-rheumatoid arthritis as a paradigm. Autoimmun Rev 8:668–671CrossRefPubMed
30.
Askenasy N, Kaminitz A, Yarkoni S (2008) Mechanisms of T regulatory cell function. Autoimmun Rev 7:370–375CrossRefPubMed
31.
Auci D, Reading C, Frincke J (2009) 7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases. Autoimmun Rev 8:369–372CrossRefPubMed
32.
Buxbaum J, Qian P, Allen P, Peters M (2008) Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun 31:208–215CrossRefPubMed
33.
Dardalhon V, Korn T, Kuchroo V, Anderson A (2008) Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 31:252–256CrossRefPubMed
34.
Egan P, van Nieuwenhuijze A, Campbell I, Wicks I (2008) Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis Rheum 58:3720–3729CrossRefPubMed
35.
Fonseca J, Santos M, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538–542CrossRefPubMed
36.
Lau A, Duong T, Ito S, Yeung R (2009) Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum 60:2131–2141CrossRefPubMed
37.
38.
Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME (2008) The consequences of apoptosis in autoimmunity. J Autoimmun 31:257–262CrossRefPubMed
39.
McMahon M, Grossman J, Skaggs B et al (2009) Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 60:2428–2437CrossRefPubMed
40.
Njoku D, Li Z, Mellerson J et al (2009) IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis. J Autoimmun 32:52–59CrossRefPubMed
41.
Omersel J, Jurgec I, Cucnik S et al (2008) Autoimmune and proinflammatory activity of oxidized immunoglobulins. Autoimmun Rev 7:523–529CrossRefPubMed
42.
Perricone C, De Carolis C, Perricone R (2009) Glutathione: a key player in autoimmunity. Autoimmun Rev 8:697–701CrossRefPubMed
43.
Profumo E, Buttari B, Rigano R (2009) Oxidized haemoglobin as antigenic target of cell-mediated immune reactions in patients with carotid atherosclerosis. Autoimmun Rev 8:558–562CrossRefPubMed
44.
Schulze C, Munoz L, Franz S et al (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8CrossRefPubMed
45.
46.
van Maanen M, Lebre M, van der Poll T et al (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 60:114–122CrossRefPubMed
47.
Yang K, Vega J, Hadzipasic M et al (2009) Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J Autoimmun 32:94–103CrossRefPubMed
48.
Derksen R, Khamashta M, Branch D (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039CrossRefPubMed
49.
Khosrotehrani K, Johnson K, Lau J, Dupuy A, Cha D, Bianchi D (2003) The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 48:3237–3241CrossRefPubMed
50.
Cutolo M, Capellino S, Sulli A et al (2006) Estrogens and autoimmune diseases. Ann N Y Acad Sci 1089:538–547CrossRefPubMed
51.
52.
Nelson J (2002) Pregnancy and microchimerism in autoimmune disease: protector or insurgent? Arthritis Rheum 46:291–297CrossRefPubMed
53.
SE FJ, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Horkko S, Witztum JL (2005) Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 52:192–200CrossRef
54.
Perricone R, Perricone C, De Carolis C, Shoenfeld Y (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7:384–390CrossRefPubMed
55.
Horne A, Stock S, King A (2008) Innate immunity and disorders of the female reproductive tract. Reproduction 135(136):739–149CrossRefPubMed
56.
Straub R, Harle P, Cutulo M et al (2006) Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of anti-inflammatory action. Arthritis Rheum 54:2039–2046CrossRefPubMed
57.
Doria A, Ghirardello A, Punzi L et al (2004) Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 51:989–995CrossRefPubMed
58.
Blank M, Cohen J, Toder V, Shoenfeld Y (1991) Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 15:3069–3073CrossRef
59.
Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y (1992) Induction of primary antiphospholipid syndrome in mice by immunization with human monoclonal anticardiolipin antibody (H-3). J Clin Invest 89:1558–1563CrossRefPubMed
60.
Cervera R, Balasch J (this issue) Autoimmunity and recurrent pregnancy. Clin Rev Allergy Immunol
61.
Avalos I, Tsokos GC (2009) The role of complement in the antiphospholipid syndrome-associated pathology. Clin Rev Allergy Immunol 36:141–144CrossRefPubMed
62.
Tincani A, Cavazzana I, Ziglioli T, Lojacono A, De Angelis V, Meroni P (this issue) Complement activation and pregnancy failure Clin Rev Allergy Immunol
63.
Adams M (2008) Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Semin Thromb Hemost 34:251–255CrossRefPubMed
64.
Palomo I, Segovia F, Alarcon M et al (2007) An insight into the pathophysiology of thrombosis in antiphospholipid syndrome. Front Biosci 12:3093–3103CrossRefPubMed
65.
Girardi G (this issue) The role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome
66.
Aoki K, Kajiura S, Matsumoto Y et al (1995) Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 345:1340–1342CrossRefPubMed
67.
De Carolis C, Perricone C, Perricone R (this issue) NK cells, auto-antibodies and immunologic infertility: a complex interplay. Clin Rev Allergy Immunol
68.
Ruiz J, Kwak J, Baum L et al (1996) Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 35:370–375PubMed
69.
Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H (1995) Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters. Am J Reprod Immunol 33:221–227PubMed
70.
Stagnaro-Green A, Roman S, Cobin R, el-Harazy E, Alvarez-Marfany M, Davies TF (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:422–1425CrossRef
71.
Bellver J, Soares S, Alvarez C et al (2008) The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod 23:278–284CrossRefPubMed
72.
Kilic S, Tasdemir N, Yilmaz N, Yuksel B, Gul A, Batioglu S (2008) The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynicol Endocrinol 24:649–655CrossRef
73.
Poppe K, Velkeniers B, Glinoer D (2008) The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 4:394–405CrossRefPubMed
74.
Kwak-Kim J, Gilman-Sachs A (2008) Clinical implication of natural killer cells and reproduction. Am J Reprod Immunol 59(5):388–400CrossRefPubMed
75.
Konova E (this issue) Role of NK cells in the autoimmune thyroid disease-associated pregnancy loss. Clin Rev Allergy Immunol
76.
Aflatoonian R, Fazeli A (2008) Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 77:7–13CrossRefPubMed
77.
Patni S, Flynn P, Wynen L et al (2007) An introduction to Toll-like receptors and their possible role in the initiation of labour. BJOG 114:1326–1334CrossRefPubMed
78.
Riley J, Nelson D (this issue) Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol
79.
Dudley D (1997) Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 36:93–109CrossRefPubMed
80.
Garland S, Ní Chuileannáin F, Satzke C, Robins-Browne R (2002) Mechanisms, organisms and markers of infection in pregnancy. J Reprod Immunol 57:169–183CrossRefPubMed
81.
Gleicher N (this issue) Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases. Clin Rev Allergy Immunol
82.
Kono D, Theofilopoulos AN (2000) Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol 19:367–387CrossRefPubMed
Metadaten
Titel
Reproductive Immunology: Current Status and Future Directions (Part I)
verfasst von
Elena Peeva
Publikationsdatum
01.12.2010
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2010
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-009-8181-7

Weitere Artikel der Ausgabe 3/2010

Clinical Reviews in Allergy & Immunology 3/2010 Zur Ausgabe

OriginalPaper

NK Cells, Autoantibodies, and Immunologic Infertility: A Complex Interplay

OriginalPaper

The Pathophysiology of the Catastrophic Antiphospholipid Syndrome: Compelling Evidence

OriginalPaper

Toll-like Receptors in Pregnancy Disorders and Placental Dysfunction

OriginalPaper

Does the Immune System Induce Labor? Lessons from Preterm Deliveries in Women with Autoimmune Diseases

OriginalPaper

Autoimmunity and Recurrent Pregnancy Losses

OriginalPaper

Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise